APOE and Alzheimer disease: To better understand the impact of AD-associated risk on LC biology prior to pTau’s ascending spread and overt LC degeneration, we performed SRT from 33 neurotypical donors without pathological AD balanced for epidemiologic AD risk factors including sex, APOE haplotypes, and genomic ancestry.